There has been a lasting and disproportionate impact of the COVID-19 pandemic on diagnosis rates for conditions including depression, asthma, and osteoporosis
Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals, and improved drug safety
The algorithm makes it possible to identify a tumor's weakness in order to personalize cancer therapy
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.